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In 1984 Sir Francis Crick hypothesized that memory is recorded in the brain as reversible modifications to DNA
and protein, but acknowledged that most biomolecules turn over too rapidly to account for long-term memories.
To accommodate this possible paradox he modeled an enzymatic mechanism to maintain modifications on
hemi-modified multimeric symmetrical molecules. While studies on the turnover of chromatin modifications that
may be involved in memory are in their infancy, an exploration of his model in the light of modern epigenetics
produced somewhat surprising results. The molecular turnover rates for two classes of chromatin modifications
believed to record and store durable memories were approximated from experiments using diverse approaches
and were found to be remarkably short. The half-lives of DNA cytosine methylation and post-translationally
modified nucleosomal histones are measured in hours and minutes, respectively, for a subset of sites on chromatin
controlling gene expression. It appears likely that the turnover of DNA methylation in the brain and in neurons, in
particular, is even more rapid than in other cell types and organs, perhaps accommodating neuronal plasticity,
learning, and memory. The machinery responsible for the rapid turnover of DNA methylation and nucleosomal
histone modifications is highly complex, partially redundant, and appears to act in a sequence specific manner.
Molecular symmetry plays an important part in maintaining site-specific turnover, but its particular role in memory
maintenance is unknown. Elucidating Crick’s paradox, the contradiction between rapid molecular turnover of
modified biomolecules and long-term memory storage, appears fundamental to understanding cognitive function
and neurodegenerative disease.
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Chromatin modifications record memories and regulate
synaptic strength
Thirty years ago, in a letter to Nature (‘Memory and mo-
lecular turnover’), Crick [1] hypothesized that memory is
‘stored in the brain’ as reversible modifications to DNA
and protein that alter ‘synaptic strength’. Only in the last
decade has it become clear that changes to the epigenome,
modifications to chromatin, such as the 5′ methylation
(5Me) of DNA cytosine (C) residues, the post-translational
modification (PTM) of nucleosomal histones (for example,
acetylation, methylation, phosphorylation), and histone
variant specific nucleosome positioning play central roles
in memory formation and maintenance and in synapse
development [2-5]. Over 100 enzymes and dozens ofCorrespondence: meagher@uga.edu
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unless otherwise stated.macromolecular machines have been identified that con-
trol the formation and turnover of chromatin modifica-
tions and the critical movement of modified nucleosomes
within and between gene sequences. To date, only a few of
these alterations to chromatin have been definitively linked
to memory formation and maintenance or to the develop-
ment of neural structures. Several diseases leading to cog-
nitive dysfunction have been associated with genetic
defects in epigenetic controls [2,6,7]. Crick’s early insight,
suggesting that secondary modifications to DNA and pro-
tein are important to memory formation and storage, has
been widely cited.The roles of molecular symmetry and turnover rates to
memory duration
Crick expressed particular concern that most known
biomolecules ‘turn over in a matter of days, weeks or at. This is an Open Access article distributed under the terms of the Creative
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term memories that might last ‘tens of years’. To accom-
modate this apparent weakness in his theory that remote
memory was stored in modified DNA and protein, he
modeled an enzymatic mechanism for the long-term
maintenance of memory based on the modification of
multimeric symmetric molecules, akin to the conserva-
tion of symmetrically methylated cytosine DNA residues
(5MeC) in a CG sequence context (Figure 1). In his ex-
ample, site-specific DNA methyltransferases (DNMTs)
recognize an unmodified cytosine base at a hemi-
modified site in the antiparallel complementary strands
of DNA and modify it, converting 5MeCG/GC to 5MeCG/
G5MeC [8]. Crick’s model highlighting the importance of
rapid molecular turnover and molecular symmetry to
memory duration has, with few exceptions, been over-
looked in the literature [3,9,10]. Beyond memory, this
model addresses the broader issue of how any cell in any
organ maintains its stable identity if its individuality isFigure 1 The rapid turnover of DNA cytosine methylation and nucleo
turnover rate of DNA cytosine methylation or nucleosomal histone PTMs, w
rate, and Co the starting concentration. Approximate turnover rates dCdte
 
(s
when neither ks nor kd = 0. Half-life (t1/2) is the time it takes for a two-fold c
5'-hydroxymethylcytosine. The half-life (t½) for
5MeC residues is estimated in
contribute to synthesis of 5mC from C, the TETs oxidize 5MeC to 5hmC and o
to the decay of 5MeC and 5hmC back to C. (C) The turnover of nucleosomal
and their PTMs are estimated in tens of minutes or less at selected sites. Nu
factors such as SWR1 and ASF1. The turnover of acetylated histone side ch
acetyl groups and histone deacetylases (for example, HDACs, SIRT1) that re
composed of four pairs of histones (large spheres) wrapped in approximate
to nucleosomal positioning and CDI are spaced 10 bp apart (yellow dots).
varying across gene regions, as indicated by the widths of the arrows.determined by protein and nucleic acid modifications
that turn over rapidly.
The turnover of DNA cytosine methylation
DNA methylation does indeed contribute to memory
formation and maintenance and is required for long-
term potentiation of neurons [3,4,9,10]. DNA methyla-
tion is considered to be one of the more stable chroma-
tin modifications and one of the few, which once newly
established, may even contribute to multi-generationally
inherited phenotypes and pathologies [11]. Further-
more, DNA methylation is often phylogenetically con-
served among recently duplicated gene sequences.
Hence, it seems counterintuitive to consider the rapid
turnover of cytosine methylation. Complex machinery is
involved in the dynamic maintenance of methylation
and has been moderately well characterized, some in re-
lation to learning and memory. For example, the DNA
cytosine-5-methyltransferases DNMT1, DNMT3a, andsomal histones. (A) The turnover rate equation. dC/dt represents the
here C is concentration, t is time, ks the synthesis rate, kd the decay
ee text) are estimated from the rate of change in modification levels,
hange in Co. (B) The turnover of DNA 5'-methylcytosine and
hours or less at selected sites. DNA methyltransferases (DNMTs)
ther products discussed in the text, and the Gadds and TETs contribute
histones and histone PTMs. The half-lives for nucleosomal histones
cleosomal histone turnover (left) is catalyzed by chromatin remodeling
ains (right) is catalyzed by lysine acetyltransferases (KATs) that add
move acetyl groups. The nucleosome is a symmetrical structure
ly 147 bp of DNA (grey line). DNA dinucleotides that may contribute
(D) The turnover of chromatin modifications is site specific with rates
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lapping roles in maintenance and in establishing new
methylation patterns involved in learning and memory
and in storing memories [9,12,13]. DNMTs require
the antiparallel symmetry of DNA for their activity
(Figure 1B). Non-coding RNAs template de novo cytosine
methylation and assist in recruiting DNMTs and RNA-
directed DNA methylation machinery (for example,
DRM1, DRM2, CMT3) to methylation sites [14-16].
The chemical turnover rates for DNA 5MeC may be
approximated from pioneering studies that assayed
dynamic changes in steady state 5MeC levels over
relatively short time periods. It is useful to recall that
the turnover rate of a molecule dCdt
 
is equal to the syn-
thesis rate (ks) minus the decay rate (kd) multiplied by
the starting concentration (Co) or dCdt ¼ ks−kd Coð Þ
 
(Figure 1A) [17]. The half-life (t1/2) of a molecule is the
time it takes for Co to increase or decrease two-fold,
when the change in concentration is dependent only
upon synthesis or decay. Most reports of dynamic
changes to 5meC levels set neither the synthesis ks nor
decay kd rates to zero, and hence, only approximate the
rate of turnover dCdt∼
 
or half-life (t1/2~). An early indi-
cation that DNA methylation regulating relevant gene
expression might turn over rapidly comes from a study
of changes in the rat hippocampal CA1 region 1 h fol-
lowing context dependent fear conditioning [13].
DNMT3a and DNMT3b transcripts increase signifi-
cantly. Methylation of a CG island (CGI) in the PP1C
promoter increases 45-fold, while methylation of a
CGI in the RELN promoter decreases two-fold within
this hour. There is an accompanying reduction in
PP1C and increase in RELN transcript levels. Hence,
the approximate turnover rate for 5MeC in these two
GCIs is 1 h or less. The levels of methylation of both
promoters returned to base line 24 h after training.
The chemical inhibitor AzaC prevents remethylation
by being incorporated into DNA and inhibiting the ac-
tivity of DNA methyltransferases. Hence, AzaC treat-
ments set the synthesis rate at incorporated sites near
to zero so that turnover rates may be more accurately
measured dCdt ¼ −kd Coð Þ
 
. Hippocampal infusion with
limited amounts of AzaC immediately after training
completely blocks contextual fear conditioning, greatly
reduces the methylation of these two promoter CGIs,
and reduces Reelin promoter methylation even lower
than with fear conditioning alone. AzaC infusion also re-
verses changes in PP1 and Reelin transcript levels. This
experiment confirms that methylation levels in these
CGIs are highly dynamic and suggests turnover rates of
less than 1 h. Subsequent studies have further supported
the rapid turnover of DNA methylation for a subset of C
residues. When AzaC is added to non-dividing cultured
cells, 10% of total 5MeC in the genome is lost after 2 h,but the level of loss increases to only 13% after 48 h of
treatment, suggesting that only a fraction of total 5MeC
sites are turning over rapidly [18].
AzaC inhibitor studies may be criticized as increasing
rates of DNA repair and perhaps the loss of 5MeC by
mechanisms not necessarily relevant to normal turnover
[19]. Alternative estimates of 5MeC minimal turnover
rates may be made, independent of the use of DNA
methylation inhibitors, based on the approximately hour-
long cycles of pS2/TFF1 transcript expression observed
when this gene is induced in multiple cell types [20].
Hour-long cycles of increased and decreased DNMT3a
and 3b expression are in phase with decreases and in-
creases in pS2 transcript levels. There are corresponding
hour-long cycles of methylation and demethylation at
eight out of 19 specific CG sites assayed in the pS2
promoter, which correlate with loss and gain of pS2 tran-
scripts, respectively. Methylation levels change several-
fold during each hourly cycle. As methylation levels
increase dramatically for 15 to 20 min of each cycle one
may presume ks is at a maximum and kd at a minimum




at eight particular 5MeC residues in the pS2
promoter region may be estimated to be significantly less
than 10 min. In summary, the turnover of a subset
of 5MeC residues appears to be extremely rapid, particu-
larly in some promoter regions (Figure 1D), validating
Crick’s concerns for one class of molecules that are in-
volved in maintaining durable memories. The mechanisms
that identify the DNA sequence context of the 5MeC sites
that turn over most rapidly remains an ongoing area of
research.
The machinery responsible for the predominant
DNA 5MeC de-methylation activities contributing to
turnover has been difficult to pin down in any tissue, let
alone de-methylation in the brain, which might impact
memory duration [21]. There are three phylogenetically-
related members in a family of non-enzymatic growth sup-
pressors, the growth arrest and DNA-damage-inducible
Gadd proteins (Gadd45a, -45b and -45 g). All three are as-
sociated with double stranded DNA repair machinery and
are expressed in the brain [22]. Gadd45a was the first
member to be linked to DNA demethylation, when it was
isolated during a screen for embryonic cDNAs capable of
activating co-transfected methylation-silenced gene en-
coding a SV40 early promoter-luciferase reporter [23].
Subsequent assays show that the transient overexpres-
sion of Gadd45a activity in HEK293T cells along with
methylation-sensitive SV40, Xbra, BRE, or TOP pro-
moter driven reporters result in the 5MeCG demethyla-
tion of the promoters and increased expression of
all four reporters within the 24 h assay [23]. The results
on reporter de-methylation parallel those using co-
treatment with AzaC or expression of the same reporters
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ther activates unmethylated as well as methylated re-
porters, while AzaC only activates methylated reporters.
This suggests that Gadd45a activity not only contributes
to the de-methylation of fully symmetrically methylated
DNA (Figure 1C), but may also overcome rapid endogen-
ous re-methylation of C to 5MeC in a fully unmethylated
context that affects the dynamics of promoter activation
and re-silencing.
The relative importance of the Gadds to the decay of
DNA methylation was challenged by two studies, in par-
ticular. First, the transient expression of Gadd45a in cul-
tured cells did not de-methylate or activate a methylated
version of a methylation-sensitive Oct4/Pou5f1 promoter
driven reporter transgene in HEK293T cells [21,24]. Sec-
ond, mice lacking the Gadd45a variant show relatively
normal development and normal methylation levels of
the endogenous Oct4 promoter DNA and of global DNA
[25]. However, a more recent study in embryonic stem
(ES) cells suggests that Gadd45a acts in conjunction
with other machinery to achieve demethylation on a
subset of sequences, such as those in the Oct4 promoter.
The demethylation and activation of methylation si-
lenced TK and Aprt promoter-reporter constructs and
endogenous pluripotency genes (Oct4/Pou5f1, Nanog)
require the co-expression of four genes involved in de-
methylation, Gadd45a, Tet1, Aid, and Mbd4 [26]. Silen-
cing any one of these four genes abolished 50% to 99%
of the demethylating activity necessary to activate each
of the four promoters. These data support the view that
the Gadds are an essential part of complex multifaceted
machinery involved in the sequence-specific control of
DNA cytosine de-methylation and turnover. Yet, there
are many unanswered questions and problems to be ad-
dressed concerning the role of Gadds in 5MeC turnover.
The three Gadd family variants are likely partially redun-
dant or overlapping in function, but the phenotypes of
double and triple Gadd mutants have not been reported.
Turnover appears to be rapid, yet none of these studies
examined Gadd45a expression constructs co-transfected
with hemi-methylated reporters, in order to assay the
contribution of endogenous remethylation and silencing
to turnover rates after methylcytosine is removed from
one strand of a 5MeCG/G5MeC sequence. Nor are their
reports of the role of Gadds in the turnover of 5MeC in
the asymmetric CH dinucleotide context, where H is T,
C, or A (Figure 1B). Gene-region-specific 5MeCH di-
nucleotide levels appear to be particularly well correlated
with neuron-specific gene expression and the develop-
ment of synaptic density in the human and mouse brain
cortex [27].
There is initial evidence that three Gadds impact neural
activity in the brain. Electroconvulsive treatment (ECT)
induces proliferation of neural progenitors and dendriticdevelopment. ECT also induces the demethylation of
specific 5MeCG dinucleotides in the BDNF and FGF-B1
promoters in neural cells of the dentate gyrus of the
hippocampus, but not measurable global DNA demethya-
tion [28]. The approximate two-fold decrease in methyla-
tion of several CG dinucleotides in the BDNF and FGF-B1
promoters, which follows 4 h after ECT, was abolished in
Gadd45b-/- mice. Transient 25- and eight-fold increases
in expression of Gadd45b and -45 g transcripts, respect-
ively, peaked 1 h after ECT, but returned to base line levels
4 h post ECT. This suggests that Gadd45b and -45 g may
contribute to a dynamic demethylation response in the
brain with the half-lives of some of the targeted 5MeC resi-
dues measured in hours. The levels of Gadd45a tran-
scripts did not change with ECT. In addition, further
evidence for the dynamic role of Gadds in methylation
turnover in neural cells comes from their co-expression
with DNMTs. When Danio rerio retinal Müller glia transi-
tion from a quiescent supportive cells to multipotent
neural progenitor cells (NPCs) following brain injury, ho-
mologs of Gadd45a and Gadd45g and four DNMTs
(DNMT1, 4, 5, 7) are concomitantly induced [29]. Simi-
larly, mouse brain NeuN-High neuronal cell nuclei with
decondensed chromatin not only express elevated levels
of transcripts involved in learning and memory and multi-
potency, but they also more highly express transcripts for
Gadd45a and -45b and DNMT1 and 3A, relative to less
epigenetically active normal-sized NeuN-Low neuronal
cell nuclei [30]. In summary, the role of the Gadd family
of repair proteins in the turnover of DNA methylation
and memory duration remains an important problem
worthy of further study, in spite of the apparent complex-
ity of various published reports.
Recently the ten-eleven-translocation (TET) gene family
(TET1, TET2, TET3) has emerged as central to removing
5MeC residues [21]. TETs are DNA dioxygenases that
catalyze the conversion of 5MeC to another biologically
active form 5′-hydroxymethylcytosine (5hmC) and require
a double stranded β-helix for their activity. TETs have
the potential go on to oxidize 5hmC first to 5′-formylcyto-
sine (5fC) and then to 5′-carboxylcytosine (5caC). They
perform all three reactions efficiently on 5MeC modified
DNA templates in vitro, but in vivo 5hmC accumulates to
much higher levels than the latter two products. DNA re-
pair enzymes convert 5caC to C completing the turnover
of 5MeC. TET generated 5hmCs in human ES cells and the
mouse fetal and adult brain cortex are found almost ex-
clusively in a CG context [27,31]. Thus, TETs have the
potential to impact the turnover of a large subset of 5MeC
residues, but are unlikely to impact the large fraction
of 5MeC residues in the CH dinucleotide context. As an
example of the potential of TETs to impact general
methylation, cultured primary cells from benign smooth
muscle leiomyoma tumors overexpress Tet1 and Tet3.
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tured primary myometrial cell controls. Partial RNAi si-
lencing of Tet1 or Tet3 expression for 24 h reduces
global DNA 5hmC by only 25%, but greatly reduced the
growth rate of leiomyoma cells [32]. As to the sequence
specificity of TET activity, Tet1 binds in or proximal to
the transcriptional start sites of 6,573 promoter se-
quences in ES cells, more than 85% of which were rich in
CG dinucleotides and most of these were also enriched
for 5MeC and 5hmC [33]. A more recent report shows that
Tet1 activity results in the accumulation of 5hmC at the
edges of methylation rich CGIs, preventing the spread of
methylation into normally unmethylated CG rich regions
[34]. Taken together current evidence suggests that TETs
act preferentially on a subset of 5MeC residues concen-
trated in promoter regions. Tet1’s demethylating activity
appears to prevent aberrant methylation and silencing of
many CG rich promoters to maintain appropriate levels
of transcription.
All three TETs are well expressed in the brain and the
importance of their synthesizing 5hmC is only recently
being understood. 5hmC levels are three-fold to 50-fold
higher in some parts of the brain such as the cerebral
cortex, than in most other organs [21,35]. The levels of
5hmC are estimated at 40% of the 5MeC levels in this re-
gion of the brain. In Purkinje and granule cell neurons
in the brain 5hmC is estimated to be 0.6% and 0.2% of
total nucleotides, respectively [36]. Tet1 deficiency is as-
sociated with defects in neural development, altered ex-
pression of neuronal transcripts, and deficiencies in
spatial learning and memory. For example, Tet1 knock-
out mice show a loss of memory extinction and reduced
expression of critical neuronal regulated transcripts Arc,
Fos, and Npas4 in the cortex and hippocampus [6]. CG
dinucleotides in the Npas4 promoter, suspected to regu-
late its transcriptional activity, are hyper-methylated in
Tet1 knockout mice. While 5hmC levels are low in the
cerebellum and hippocampus of 7-day-old mice, the
levels of 5hmC increase two- to five-fold, respectively, in
the 6-week-old and adult mice [37]. In these later stages
almost half of modified cytosines in CG context in these
regions of brain are 5hmC. Other studies found that the
levels of 5hmC are low in the mouse brain cortex at con-
ception, but increase rapidly to near adult levels 6 weeks
later, increasing concordantly with increases in synapto-
genesis [27,37]. Finally, in the fetal mouse brain Tet2
activity appears necessary to hydroxymethylate the few
percent of 5MeC residues destined to be demethylated at
later states in development [27]. The tantalizing impli-
cation from these studies is that the TET-enzyme activ-
ity and 5hmC-dependent turnover rate of 5MeC may be
higher in the brain to assist with more rapid responses
of the neuronal methylome to learning and memory.
But these results only increase the concern for Crick’sparadox, because more rapid TET-dependent turnover
works against 5MeC-dependent memory duration.The turnover of nucleosomal histone side chain
modifications
Gene-specific nucleosomal histone PTMs are involved in
memory formation, sometimes changing in a matter of
minutes after a stimulus, and also contributing to durable
memory formation [3,4]. There is only limited evidence
that gene-specific histone PTMs are multi-generationally
inherited and PTMs are rarely phylogenetically inherited
among duplicated regions of DNA [11]. This suggests
PTMs are more transient than DNA methylation and
might turnover more rapidly. Turnover rates for nucleo-
somal histone variants and by default, histone PTMs,
were approximated from experiments that examined
changes in their levels over short time periods. A pio-
neering report in 1990 examined the incorporation of
tritiated acetate into the major histone variants (H2A,
H2B, H3, H4) in dividing cells without and with the
addition of the HDAC inhibitor trichostatin A (TSA)
[38]. This and subsequent related pulse-chase labeling
experiments using HDAC inhibitors estimated the half-
lives (t½) of acetylated histone variants are in the range
of 2 to 40 min dCdt ¼ ks
 
[39]. Another set of turnover
rate measurements were made independent of the use of
inhibitors or isotope incorporation in yeast with cells
arrested in the G1 phase of growth. Turnover rate
estimates may be made based on the approach-to-steady-
state increases of histone incorporation into nucleo-
somes, after induction of transgenes expressing epitope
tagged histone variants dCdt ¼ ks
 
. These studies are lim-
ited by the rate at which tagged variants are newly syn-
thesized and reach a high enough steady state levels to
compete maximally with endogenous histone variants.
The rate of tagged histone H2b incorporation into nucle-
osomes suggests a turnover rate of less than 30 min for
nucleosomes associated with both transcriptionally active
and inactive genes [40]. Similarly, rate of incorporation of
tagged histone H3 into nucleosomes, suggests half-life of
the H3 variant may be less than 10 min for the ‘hottest’
most actively replaced nucleosomes relative to H3 in-
corporation into other nucleosomes, which turn over
with half-lives estimated in hours or longer [41]. These
studies also suggest that in yeast nucleosomal histone
turnover rates were relatively low in actively transcribed
gene regions, but high in the proximal regions of
promoters.
A genome wide steady state measurement of histone
variant turnover rates dCdt ¼ ks
 
was made in cultured in-
sect cells independent of transgene induction lag times
using the methionine analog azidohomoalanine (Aha).
Aha is rapidly incorporated into protein after its addition
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phase cells are given short pulses of Aha, nucleosomes are
purified, and nucleosomal Aha is specifically chemically
coupled to biotin. Newly made biotin-tagged nucleosomes
are affinity purified and associated DNA quantified across
the genome. Because the levels of nucleosomal Aha label-
ing of gene-region specific DNA sequences in active genes
appears nearly complete after a 20 min pulse of Aha, the
half-life (t½) for histone proteins within nucleosomes in
these gene regions may estimated to be less than 10 to
20 min, but may occur more slowly in flanking promoter/
enhancer regions (Figure 1D). In summary, the discord-
ance between the short half-lives of this major class of
modified biomolecules implicated in memory formation
and memory duration is extreme.
Following the symmetry argument in Crick’s model for
maintaining modifications, the symmetrical pairing of the
four core histones (for example, two histone H4 subunits,
two H2b subunits, and so on) in a nucleosome might dir-
ect the re-modification of hemi-modified histone pairs in
nucleosomes. A model utilizing nucleosomal symmetry
analogous to that for the activity of DNMT1 on hemi-
methylated DNA is imagined. However, one such study
shows that the symmetrical pairing of differentially modi-
fied H4 subunits accounts for maintaining only a small
fraction of the two histone H4 PTMs assayed, H4K20me2
and H4K20me3 [43]. Hence, nucleosomal symmetry may
represent only a partial solution to the problem of histone
PTM maintenance. Moreover, no such measurements
taking into account the symmetry of PTMs have been
reported for the brain.
Complex models for the deposition and turnover of nu-
cleosomes with particular modified histone compositions
have been proposed that preserve their position in chro-
matin, a process known as chromatin domain inheritance
(CDI). CDI is of necessity linked to DNA replication,
DNA repair, and transcription, but must be considered in
any nucleosomal histone turnover model. Because it is
hard to imagine a complete physical mechanism for the
CDI of properly modified nucleosomes following replica-
tion or transcription, it is reassuring that numerous
proteins and multiprotein complexes contributing to
replicative CDI have been identified, including proliferat-
ing cell nuclear antigen, mini-chromosome maintenance
complex, the histone chaperone anti-silencing factor 1
(ASF1), chromatin assembly factor 1, and histone variant
exchange complexes (for example, SWR1) [44-47]. As
an example activity, histones H3 and H4 bound to
ASF1 are deposited on both strands of the newly repli-
cated DNA followed by H2A and H2B. Yet, in spite of
progress understanding some of the mechanics of
histone and nucleosome deposition and conservation
beyond a DNA replication fork, the precise factors
that determine CDI and how this entire processimpacts durable memory-related gene expression re-
main illusive.
One major problem for understanding CDI has been
that chromatin domains for nucleosomes were not pre-
viously thought of as DNA-sequence specific, and
hence, the antiparallel symmetry of DNA did not seem
relevant. However, a consensus rotational palindromic
repeat of 10.5 bp (R-YYYYYRRRRR-Y, R = purine, Y =
pyrimidine) that bends correctly around and binds the
eight core nucleosomal histones was revealed using ad-
vanced computational methods to examine tens of
thousands of nucleosome-delimited 147 base pair (bp)
DNA sequences from yeast, plants, and humans [48].
Typically on the order of several to 10 dinucleotides
from among the 14 repeats of the DNA double helix
have the correct sequence and orientation to bind and
position the nucleosome (yellow dots, Figure 1C) [49].
Because DNA residues are contacting particular histone
subunit amino acid residues, the exact histone variant
composition and perhaps histone PTMs in the nucleo-
some appear to determine the sequence-specificity for
nucleosome binding and positioning. For example,
nucleosomes containing the histone variant H2AZ that
are enriched arround transcriptional start sites and
nucleosomes containing the centromeric histone 3
(CENH3) that are highly enriched within centromeres
each contact different dinucleotide consensus se-
quences [11,50,51]. In a recent study, Zovkic et al. [5]
show that there is a rapid exchange of the two H2AZ
variant nucleosomes immediately flanking the tran-
scription start site of memory-related genes in the CA1
region of the hippocampus following fear conditioning
(that is, remote memory and memory consolidation)
[5]. In short, one key to the CDI of nucleosome specific
histone PTMs associated with genes involved in mem-
ory maintenance may lie in the symmetrical double-
strand DNA sequence-specific code for nucleosome
positioning.
Current limitations and future studies on memory and
molecular turnover
It is worth noting that most of the literature on the
turnover of chromatin structures does not come from
the CNS. With few exceptions, the examples measuring
molecular turnover associated with direct measure-
ments of memory acquisition, consolidation, remote
(long-term) memory, and extinction come from the
best-studied model system for learning-related plasti-
city, the hippocampus. Yet, the latter of these memory
processes involve a dialog with neurons in other regions
of the brain such as the neocortex [52,53]. Linked cor-
tical neurons are undoubtedly being reprogrammed
through dynamic changes in epitype that are not being
measured. Perhaps the extension of new technologies,
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isolation of nuclei tagged in specific cell types (IN-
TACT) in the brain will enable the analysis of turnover
in different classes of neurons from multiple regions of
the brain [27,30,54].
Also beyond the scope of current research is the dis-
secting possibility that the thousands of synaptic con-
nections formed by one neuron are recorded or
programmed as combinatorial genome-wide changes
to numerous different chromatin structures that must
be maintained or strengthened for remote memories
[55]. A cubic millimeter of the mammalian neocortex
contains nearly a hundred thousand neurons with as
many as an hundred million synapses [56], whose syn-
aptic strength must be rapidly regulated. It is hard to
conceive that changes in epitype in the nucleus of each
neuron direct such complexity, even if the combinator-
ial capacity exists in the epigenome. Non-chromatin
associated decentralized epigenetic phenomena such
as the localization of mRNAs (for example, MKK7,
PKMζ) and non-coding RNAs (for example, miR-124)
contribute to neurite- and synapse-specific gene ex-
pression [57-59]. Further, memory-related transcrip-
tional regulatory proteins (for example, CRTC1) may
be localized near synapses and subsequently trans-
ported to the nucleus to couple synaptic transmission
with transcription [60,61]. Yet, RNA and protein trans-
port and their cytoplasmic positioning for remote mem-
ory may be programmed by chromatin-modifications,
modifications that must be maintained for some period
and are subject to molecular turnover. Such unresolved
issues highlight the early pioneering stage of research on
the epigenetics of long-term memory.
Conclusions
Crick’s model highlighting the importance of molecular
turnover and the role of molecular symmetry to memory
duration appears to have been way ahead of its time and
is worthy of serious consideration as we explore the mo-
lecular bases of memory. Loss of normal epigenetic con-
trol and defects in remote memory are part of most
cognitive disorders, including Alzheimer’s disease, Rett
syndrome, Rubinstein-Taybi syndrome, Prader-Willi syn-
drome, Schizophrenia, Fragile X mental retardation, and
major depression [6,7,62]. Defects in histone PTMs
and DNA methylation have been strongly implicated in
the loss of cognitive function and memory and most
of these disorders. Beyond the role of symmetry in
CG methylation, little is known about the contribution
of molecular symmetry to maintaining modifications
in relevant protein complexes such as the nucleo-
some. Closing the gap between understanding memory
duration and the maintenance of chromatin modifica-
tions in the face of rapid molecular turnover appearsparamount to the study of neurobiology and neurode-
generative disease.General abbreviations
AzaC (5-aza-2′-deoxycytidine), Aha (azidohomoalanine),
bp (base pair), BER (base excision repair), CDI (chromatin
domain inheritance), CGI (CG rich Islands), CNS (central
nervous system), ECT (Electroconvulsive treatment), ES
cells (embryonic stem cells), HEK293T cells (human
embryonic kidney 293 cells), histone PTM (histone
post-translational modification), INTACT (isolation of
nuclei tagged in specific cell types) [63,64], NPC (neural
progenitor cell), 5MeC (5′-methylcytosine), 5hmC (5′-
hydroxymethylcytosine), 5fC (5′-formylcytosine), 5caC
(5′-carboxylcytosine), RNAi (RNA interference), TDG
(thymine-DNA glycosylase).Protein/gene abbreviations
Aid/AICDA (Activation-Induced Cytidine Deaminase),
Aprt (adenine phosphoribosyltransferase), APC/PPP1R46
(Adenomatous Polyposis Coli), ARC (Activity-regu-
lated cytoskeleton-associated protein), ASF1 (histone
chaperone anti-silencing factor 1), BDNF (Brain-de-
rived neurotrophic factor), BRE/BRACC45 (Brain
And Reproductive Organ-Expressed), BRN2/ POU3F2
(Brain-specific 2/N gene, POU domain class 3 homeo-
box 2), CENH3 (centromeric histone 3), CRTC1
(CREB-regulated transcriptional coactivator), CRYAA/
CRYA1 (Crystallin, Alpha A), DAZ1/SPGY (Deleted In
Azoospermia 1), DNMTs (DNA methyltransferases 1,
3A, 3B from mammals and 1 4, 5, 7 from fish), DRM1,
DRM2, CMT3 (RNA directed de novo DNA methyl-
transferases), FGF-B1/FGF2 (Fibroblast growth factor
1 basic), Fos (FBJ Murine Osteosarcoma Viral Onco-
gene Homolog), GADD45a, GADD45β and GADD45g
(DNA cytosine demethylases, Growth arrest DNA
damage inducible protein isoforms), HDAC (histone
deacetylase), H2AZ (histone 2a, isoform Z), Mbd4/MED1
(Methyl-CpG Binding Domain Protein 4), MeCP2 (me-
thyl-CpG binding protein 2), MKK7 (mitogen-activated
protein kinase kinase 7), MYD118 (myeloid differenti-
ation primary response factor), microRNA 124 (miR-
124), Npas4 (Neuronal PAS Domain Protein 4), NeuN/
RBFOX3 (Neuronal nuclei, Hexaribonucleotide Binding
Protein 3), OCT4/POU5F1 (Octamer-binding transcrip-
tion factor 4, PKMζ (protein kinase M zeta), POU domain,
class 5, transcription factor 1), PP1C/PP1Cγ/PPP1G
(serine threonine protein phosphatase 1, gamma subunit),
pS2/BEC1 (Breast Cancer Estrogen-Inducible Protein,
Trefoil Factor 1), RELN (Reelin), SV40 (simian vacuolating
virus 40), TET1, 2, 3 (ten-eleven-translocation DNA
dioxygenases), TK1 (Thymidine kinase 1), TOP1 (Topoiso-
merase DNA 1), Xbra (Xenopus brachyury).
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